Business context and reporting period
USEC Inc. (the issuer named in this 10-Q; the request identifies Centrus Energy Corp.) reported the quarter and six months ended June 30, 2014. USEC supplied low-enriched uranium (LEU) and performed government contract work. It had ceased enrichment at the Paducah plant in May 2013 and was transitioning the site back to the Department of Energy (DOE). USEC Inc. filed for Chapter 11 on March 5, 2014; its operating subsidiaries were not debtors in the case.
Financial performance and liquidity
| Metric | Three months ended June 30, 2014 | Six months ended June 30, 2014 |
|---|---|---|
| Revenue | $121.2 million, down 57% year over year | $269.8 million, down 55% |
| Gross profit (loss) and margin | $3.5 million; 2.9% margin, versus a $46.9 million loss | $(17.4) million; (6.4)% margin, versus a $33.6 million loss |
| Operating loss | $(18.7) million | $(57.9) million |
| Net loss | $(28.0) million, or $(5.71) per share | $(78.8) million, or $(16.08) per share |
| Operating cash flow | Not separately reported in the filing for the quarter | $(193.4) million |
At June 30, cash and cash equivalents were $123.3 million, down from $314.2 million at year-end 2013. The six-month cash decline was $190.9 million. Working capital was a deficit of $242.3 million. Total assets were $807.7 million, total liabilities $1.344 billion, and stockholders’ deficit $536.2 million. The company had $530 million of convertible senior notes due October 1, 2014; following the bankruptcy filing, pre-petition claims were presented as $658.2 million of liabilities subject to compromise, including notes and accrued interest, preferred stock, and other claims.
Cash burn included payment of $340.7 million of Russian Contract payables. Inventory and receivables reductions provided cash as the company monetized previously acquired material. The parent debtor reported only $7.4 million of cash at June 30 and depended on funding from its operating subsidiary. A $50 million subsidiary-provided debtor-in-possession facility carried 10.5% interest; USEC borrowed $42.3 million and repaid $30.8 million during the six months.
Material changes versus the prior comparable period
- Second-quarter revenue fell $163.6 million year over year, mainly because SWU sales volume declined 65%; six-month SWU volume fell 56%. No uranium revenue was recorded in 2014. Average SWU prices billed increased 8% in the quarter and 1% for the six months.
- Gross profit improved in the quarter and the six-month period, chiefly because Paducah-related non-production expenses were lower. Those expenses were $14.3 million in Q2 2014 versus $70.0 million in Q2 2013, and $49.2 million versus $75.7 million for the six months.
- Contract-services revenue rose to $16.7 million for the quarter and $19.7 million for six months, including work under the new American Centrifuge Technology Demonstration and Operations Agreement (ACTDO) beginning May 1.
- Advanced technology costs declined to $18.0 million in Q2 and $51.3 million for six months as the former DOE cooperative agreement ended April 30 and the new program had a narrower scope. USEC recorded $13.1 million of reorganization items for the six months.
- The balance sheet changed substantially following Chapter 11: $658.2 million of liabilities were classified as subject to compromise, while cash, receivables, inventories and deferred costs fell materially from year-end levels.
Guidance, outlook, risks and unusual items
- Management expected 2014 sales volume at about 30% of the 2008–2012 annual average of approximately 11 million SWU. It projected cash above $50 million at September 30 and above $150 million at year-end, while noting that guidance was limited by restructuring and uncertain government funding.
- The bankruptcy plan was subject to creditor votes and court confirmation. As described in the filing, existing common shareholders were slated to receive 5% of reorganized common stock, subject to dilution; noteholders would receive 79.04%, and preferred investors 15.96%, also subject to dilution. The plan proposed replacing the $530 million notes with $200 million of new notes and equity, among other consideration. Confirmation, exit financing, government consent for certain agreements, and final plan terms remained uncertain.
- On July 31, 2014, after quarter-end, ORNL exercised a six-month ACTDO extension through March 31, 2015, increasing the contract price from approximately $33.7 million to $75.3 million. Funding then allotted was expected to cover work only through August 31, 2014; further funding and another option remained uncertain.
- USEC estimated limited American Centrifuge demobilization costs below $20 million in the second half of 2014, but warned actual costs could be higher. At current market prices—described as the lowest SWU levels in more than a decade—management said prior commercialization plans were not economically viable without improved conditions or additional government support. Commercial deployment would require substantial new capital.
- Paducah return to DOE was targeted for October 1, 2014, subject to DOE readiness, appropriations, and USEC completing turnover requirements. Transition, severance, inventory-management, and site costs could exceed estimates. The company also faced risk of customer contract changes or termination as supply sources shifted.
- Defined-benefit plans were underfunded. The PBGC had preliminarily estimated approximately $130 million of potential ERISA Section 4062(e) liability tied to Portsmouth; USEC disputed both liability and amount, and potential Paducah exposure could be greater. The company expected $28.7 million of pension contributions in 2014.
- Other material uncertainties included the going-concern qualification, possible NYSE delisting, DOE rights under the 2002 agreement and the missed June 2014 milestone, pending DOE contract claims, and the risk that the American Centrifuge issue identified in February 2014 could raise future maintenance costs. Management stated disclosure controls were effective at a reasonable assurance level.
Important facts for investors to verify
- Confirm the issuer identity: this source is USEC Inc.’s 2014 10-Q, not a filing bearing the Centrus Energy Corp. name.
- Verify the eventual Chapter 11 plan, effective ownership dilution, new debt, exit financing, and treatment of existing common stock.
- Track actual cash generation, subsidiary support and DIP/exit-facility availability against management’s cash outlook.
- Check DOE funding and ACTDO performance periods, plus the costs and timing of Paducah turnover and centrifuge demobilization.
- Follow PBGC actions and resolution of DOE receivables and claims, including potential pension-related exposure.
- Assess whether lower delivery volumes, customer contract changes, and weak SWU prices materially alter backlog value and the viability or financing of commercial centrifuge deployment.